Plain-English translation of NCT04084496 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Pancreatic Cancer research guide →Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing whether mFOLFIRINOX—a combination of four chemotherapy drugs—can help people with pancreatic cancer stay cancer-free longer after surgery. The study involves about 80 patients in China who have had their pancreatic tumors surgically removed. The medication is given every two weeks for 6 months to try to destroy any remaining cancer cells that might not be visible after surgery.
Pancreatic cancer often comes back even after surgery removes the tumor. Researchers want to know if giving chemotherapy after surgery can reduce the chance of recurrence and help patients live longer and healthier lives.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will receive the chemotherapy medication as an intravenous (IV) infusion every 2 weeks for 6 months. Each treatment involves multiple drugs given on the same day, with one drug delivered continuously over about 2 days. You will have regular blood tests and check-ups to monitor how well you are tolerating the treatment and how your health is progressing. The study will track whether your cancer stays away, how long you survive, any side effects you experience, and how the treatment affects your quality of life.
AI-generated summary from trial data · Jul 15, 2026 · Not medical advice
China